Search
for
Sort by
Research 181–210 of 1000+
- Cutaneous drug reactions
- Use of genetics in the prediction of success in male pattern hair loss therapy and mechanistic studies
- Analysis of metabolic characteristics of epristeride in zebrafish based on LC-Q-TOF MS and its potential applications in doping control
- A Natural Inhibitor, 1′S-1′-Acetoxychavicol Acetate, Against Testosterone-Induced Alopecia via NADPH Oxidase Regulation
- Keratosis Pilaris-like Eruption during Treatment of Chronic Myeloid Leukemia with Tyrosine Kinase Inhibitors: Literature Review and Report of a Case Related to Imatinib
- Hormone Blocking Anticancer Drugs
- The role of dutasteride in the treatment of benign prostatic obstruction and related conditions
- Icariside II inhibits gastric cancer progression by suppressing the Wnt/β-catenin signaling pathway
- Evaluation of retardant property of green hair growth retardant formula
- Linking diet to acne metabolomics, inflammation, and comedogenesis: an update
- Safety of Tyrosine Kinase Inhibitors in Patients With Differentiated Thyroid Cancer: Real-World Use of Lenvatinib and Sorafenib in Korea
- Adverse Effects and Safety of 5-alpha Reductase Inhibitors (Finasteride, Dutasteride): A Systematic Review.
- Incidence of type 2 diabetes mellitus in men receiving steroid 5α-reductase inhibitors: population based cohort study
- Penile vascular abnormalities in young men with persistent side effects after finasteride use for the treatment of androgenic alopecia
- Change in hair growth-related gene expression profile in human isolated hair follicles induced by 5-alpha reductase inhibitors – dutasteride and finasteride – in the presence of testosterone
- Epidermal growth factor receptor inhibitor Geftinib-induced erosive pustular dermatosis of the scalp – A report with a brief review of the literature
- Adenovirus-Mediated Wnt5a Expression Inhibits the Telogen-To-Anagen Transition of Hair Follicles in Mice
- Sexual Dysfunctions Related to Drugs Used in the Management of Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia: A Narrative Review on α-Blockers and 5-Alpha Reductase Inhibitors
- Effect of 5-alpha reductase inhibitors in animal models of Parkinson’s disease
- How Does pH Fit in with Oscillating Polar Growth?
- Caffeic acid N-[3,5-bis(trifluoromethyl)phenyl] amide as a non-steroidal inhibitor for steroid 5α-reductase type 1 using a human keratinocyte cell-based assay and molecular dynamics
- Efficacy and safety of the oral Janus kinase 3/tyrosine kinase expressed in hepatocellular carcinoma family kinase inhibitor ritlecitinib over 24 months: integrated analysis of the ALLEGRO phase IIb/III and long-term phase III clinical studies in alopecia areata
- Alopecia Areata: an Update on Etiopathogenesis, Diagnosis, and Management
- Targeting of Smoothened for therapeutic gain
- Upadacitinib for Successful Treatment of Alopecia Universalis in a Child: A Case Report and Literature Review
- Regulation of stem cell fate by HSPGs: implication in hair follicle cycling
- Roles of the Hedgehog Signaling Pathway in Cutaneous Physiology and Oncology
- Roles of the Hedgehog Signaling Pathway in Epidermal and Hair Follicle Development, Homeostasis, and Cancer
- Childhood Alopecia Areata: An Overview of Treatment and Recent Patents
- Mommy — where do tumors come from?